Baidu
map

中医科指南

订阅

MedSci主页 / 所有栏目 / 中医科指南

脓疱疮中医治疗专家共识

2019-04-30 中华中医药学会皮肤科专业委员会 中国中西医结合皮肤性病学杂志.2019,18(2):175-176.

脓疱疮中医治疗

脓疱疮是一种发于皮肤有传染性的化脓性皮肤病。其特征为发生丘疹、水疱或脓疱，易破溃而结成脓痂。系接触传染，蔓延迅速。古代文献又称“黄水疮”、“滴脓疮”、“天疱疮”等。好发于儿童，可发于任何部位，但多以面部等暴露部位为主。

中文标题：

脓疱疮中医治疗专家共识

发布机构：

中华中医药学会皮肤科专业委员会

发布日期：

2019-04-30

简要介绍：

脓疱疮是一种发于皮肤有传染性的化脓性皮肤病。其特征为发生丘疹、水疱或脓疱，易破溃而结成脓痂。系接触传染，蔓延迅速。古代文献又称“黄水疮”、“滴脓疮”、“天疱疮”等。好发于儿童，可发于任何部位，但多以面部等暴露部位为主。

拓展指南：与脓疱疮相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=脓疱疮中医治疗专家共识)] GetToolGuiderByIdResponse(projectId=1, id=c77441c001ea388b, title=脓疱疮中医治疗专家共识, enTitle=, guiderFrom=中国中西医结合皮肤性病学杂志.2019,18(2):175-176., authorId=null, author=, summary=脓疱疮是一种发于皮肤有传染性的化脓性皮肤病。其特征为发生丘疹、水疱或脓疱，易破溃而结成脓痂。系接触传染，蔓延迅速。古代文献又称“黄水疮”、“滴脓疮”、“天疱疮”等。好发于儿童，可发于任何部位，但多以面部等暴露部位为主。 , cover=, journalId=null, articlesId=null, associationId=874, associationName=中华中医药学会皮肤科专业委员会, associationIntro=null, copyright=0, guiderPublishedTime=Tue Apr 30 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<div>脓疱疮是一种发于皮肤有传染性的化脓性皮肤病。其特征为发生丘疹、水疱或脓疱，易破溃而结成脓痂。系接触传染，蔓延迅速。古代文献又称“黄水疮”、“滴脓疮”、“天疱疮”等。好发于儿童，可发于任何部位，但多以面部等暴露部位为主。</div> <div><br> </div>拓展指南：<strong>与<font color=red>脓疱疮</font>相关指南：</strong><br><ul><li><a href="//m.capotfarm.com/guideline/show_article.do?id=d96101c00132933a" title="复方黄柏液涂剂治疗儿童湿疹、脓疱疮、特应性皮炎专家共识（2016年）" target=_blank>复方黄柏液涂剂治疗儿童湿疹、脓疱疮、特应性皮炎专家共识（2016年）</a></li> 更多信息请点击：<a href="//m.capotfarm.com/guideline/list.do?q=%E8%84%93%E7%96%B1%E7%96%AE" target=_blank>有关脓疱疮更多指南</a></ul>, tagList=[TagDto(tagId=90411, tagName=脓疱疮), TagDto(tagId=42967, tagName=中医治疗)], categoryList=[CategoryDto(categoryId=37, categoryName=中医科, tenant=100), CategoryDto(categoryId=39, categoryName=皮肤性, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=7424, appHits=213, showAppHits=0, pcHits=4923, showPcHits=3118, likes=76, shares=13, comments=6, approvalStatus=1, publishedTime=Thu May 30 22:30:16 CST 2019, publishedTimeString=2019-04-30, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Thu May 30 22:30:16 CST 2019, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 20:13:26 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=脓疱疮中医治疗专家共识)])
脓疱疮中医治疗专家共识
下载请点击：
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2215392, encodeId=b42e2215392e0, content=在学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcaa9389021, createdName=ms4000002045391164, createdTime=Wed Jul 17 12:35:39 CST 2024, time=2024-07-17, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=1069753, encodeId=9a361069e53a9, content=学习了，看看看看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2365708867, createdName=ms2000001551511705, createdTime=Fri Nov 12 22:20:31 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067423, encodeId=ed3f106e423b6, content=学习的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/15/7274ed1be4747d648e4e2f7f62fae403.jpg, createdBy=d8d65273314, createdName=1482963am12暂无昵称, createdTime=Fri Nov 05 22:48:40 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009896, encodeId=de951009896f0, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5635109148, createdName=1460eeeam59暂无昵称, createdTime=Sat Aug 21 06:40:31 CST 2021, time=2021-08-21, status=1, ipAttribution=)]
    2024-07-17 ms4000002045391164 来自甘肃省

    在学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2215392, encodeId=b42e2215392e0, content=在学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcaa9389021, createdName=ms4000002045391164, createdTime=Wed Jul 17 12:35:39 CST 2024, time=2024-07-17, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=1069753, encodeId=9a361069e53a9, content=学习了，看看看看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2365708867, createdName=ms2000001551511705, createdTime=Fri Nov 12 22:20:31 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067423, encodeId=ed3f106e423b6, content=学习的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/15/7274ed1be4747d648e4e2f7f62fae403.jpg, createdBy=d8d65273314, createdName=1482963am12暂无昵称, createdTime=Fri Nov 05 22:48:40 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009896, encodeId=de951009896f0, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5635109148, createdName=1460eeeam59暂无昵称, createdTime=Sat Aug 21 06:40:31 CST 2021, time=2021-08-21, status=1, ipAttribution=)]
    2021-11-12 ms2000001551511705

    学习了，看看看看

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2215392, encodeId=b42e2215392e0, content=在学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcaa9389021, createdName=ms4000002045391164, createdTime=Wed Jul 17 12:35:39 CST 2024, time=2024-07-17, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=1069753, encodeId=9a361069e53a9, content=学习了，看看看看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2365708867, createdName=ms2000001551511705, createdTime=Fri Nov 12 22:20:31 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067423, encodeId=ed3f106e423b6, content=学习的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/15/7274ed1be4747d648e4e2f7f62fae403.jpg, createdBy=d8d65273314, createdName=1482963am12暂无昵称, createdTime=Fri Nov 05 22:48:40 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009896, encodeId=de951009896f0, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5635109148, createdName=1460eeeam59暂无昵称, createdTime=Sat Aug 21 06:40:31 CST 2021, time=2021-08-21, status=1, ipAttribution=)]
    2021-11-05 1482963am12暂无昵称

    学习的

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2215392, encodeId=b42e2215392e0, content=在学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcaa9389021, createdName=ms4000002045391164, createdTime=Wed Jul 17 12:35:39 CST 2024, time=2024-07-17, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=1069753, encodeId=9a361069e53a9, content=学习了，看看看看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2365708867, createdName=ms2000001551511705, createdTime=Fri Nov 12 22:20:31 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067423, encodeId=ed3f106e423b6, content=学习的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/15/7274ed1be4747d648e4e2f7f62fae403.jpg, createdBy=d8d65273314, createdName=1482963am12暂无昵称, createdTime=Fri Nov 05 22:48:40 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009896, encodeId=de951009896f0, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5635109148, createdName=1460eeeam59暂无昵称, createdTime=Sat Aug 21 06:40:31 CST 2021, time=2021-08-21, status=1, ipAttribution=)]
    2021-08-21 1460eeeam59暂无昵称

    学习了

    0

Baidu
map
Baidu
map
Baidu
map